Research and Markets: Anorexia Nervosa Therapeutics Market - Absence of Approved Therapy Leave High Unmet Need in the Market

DUBLIN--(BUSINESS WIRE)-- Research and Markets (http://www.researchandmarkets.com/research/07153f/anorexia_nervosa_t) has announced the addition of GlobalData's new report "Anorexia Nervosa Therapeutics - Pipeline Assessment and Market Forecasts to 2018" to their offering.

GlobalData, the industry analysis specialist, has released its new report, Anorexia Nervosa Therapeutics - Pipeline Assessment and Market Forecasts to 2018. The report is an essential source of information and analysis on the global therapeutics market, identifying the key trends shaping and driving the global anorexia nervosa therapeutics market. The report also provides insights on the prevalent competitive landscape and the emerging players expected to significantly alter the market positioning of the current market leaders.

Most importantly, it provides valuable insights on the pipeline products within the global anorexia nervosa therapeutics sector. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

GlobalData analysis indicates that the global anorexia nervosa therapeutics market was worth $12.7m in 2010 and will grow at a Compound Annual Growth Rate (CAGR) of 8.9% to $25m by 2018. The future market is set to witness steady growth until 2018, primarily attributed to an increasing patient pool and public awareness of the disorder. Molecule SUN11031 (human ghrelin hormone) from Daiichi Sankyo is expected to be launched in Japan in 2014 but is not expected to be a significant driver for the anorexia therapeutics market. A low treatment rate, the high cost of therapy, non - supportive government reimbursement policies and non - availability of an approved therapy able to completely cure anorexia will act as barriers to market growth.

Read more inside Anorexia Nervosa Therapeutics Market.

Companies Mentioned:

• Daiichi Sankyo Company Ltd

For more information visit http://www.researchandmarkets.com/research/07153f/anorexia_nervosa_t